To compensate, cardiomyocytes shift to glycolysis for basic energy needs, although this source is insufficient for normal cardiac activity
(2014) enrolled subjects for what was claimed to be a 12-week trial, but these data are now unreliable due to fabrication Community use: Anecdotal reports of years of use exist, but these are unstructured observations without systematic health monitoring No cancer surveillance: No prospective study has tracked cancer incidence in Dihexa users No organ toxicity assessment: Liver, kidney, and other organ function have not been formally evaluated over time No neurological outcomes: Long-term neuroimaging, cerebrospinal fluid biomarkers, or advanced cognitive assessments have not been performed Unknown delayed effects: Some toxicities emerge only after months or years of exposure (e.g., certain chemotherapy agents cause cardiomyopathy years after treatment) The absence of long-term safety data is not reassuring
Looking Beyond the Label: The Quality Checklist Finding the best supplement isn't just about the delivery method
World J Microbiol Biotechnol 21:10951101 Alesandrini F, Mathis R, Van de Sype G, Hrouart D, Puppo A (2003) Possible roles of a cysteine protease and hydrogen peroxide in soybean nodule development and senescence